Moderna CMO sells shares as final vaccine trials begin, raising concerns
CEO Stéphane Bancel has also cashed out on shares in recent months.
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: BRIAN SNYDER/REUTERS)ByJERUSALEM POST STAFF
